Literature DB >> 11292030

Variable expression of activation-linked surface antigens on human mast cells in health and disease.

P Valent1, G H Schernthaner, W R Sperr, G Fritsch, H Agis, M Willheim, H J Bühring, A Orfao, L Escribano.   

Abstract

Mast cells (MC) are multipotent effector cells of the immune system. They contain an array of biologically active mediator substances in their granules. MC also express a number of functionally important cell surface antigens, including stem cell factor receptor (SCFR=kit=CD117), high affinity IgER (FcepsilonRI), or CSaR (CD88). Respective ligands can induce or promote degranulation, migration, or cytokine production. Other integral surface molecules can mediate adhesion or cell aggregation. Recent data suggest that a number of critical molecules are variably expressed on the surface of human MC. In fact, depending on the environment (organ), stage of cell maturation, type of disease, and other factors, MC express variable amounts of activation-linked antigens (CD25, CD63, CD69, CD88), cell recognition molecules (CD2, CD11, CD18, CD50, CD54), or cytokine receptors. At present, however, little is known about the mechanisms and regulation of expression of such antigens. The present article gives an overview of MC phenotypes in health and disease, and attempts to provide explanations for the phenotypic variability of MC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292030     DOI: 10.1034/j.1600-065x.2001.790108.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  12 in total

1.  Accumulation of CD1a-positive Langerhans cells and mast cells in actinic cheilitis.

Authors:  Caliandra Pinto Araújo; Clarissa Araújo Silva Gurgel; Eduardo Antônio Gonçalves Ramos; Valéria Souza Freitas; Aryon de Almeida Barbosa; Luciana Maria Pedreira Ramalho; Jean Nunes dos Santos
Journal:  J Mol Histol       Date:  2010-10-02       Impact factor: 2.611

2.  Distribution of mast cells in benign odontogenic tumors.

Authors:  Francisco de Assis Caldas Pereira; Clarissa Araújo Silva Gurgel; Eduardo Antônio Gonçalves Ramos; Manuela Torres Andion Vidal; Antônio Luiz Barbosa Pinheiro; Vladimir Jurisic; Caroline Brandi Schlaepfer Sales; Patrícia Ramos Cury; Jean Nunes dos Santos
Journal:  Tumour Biol       Date:  2011-11-30

3.  Mast cell distribution in normal adult skin.

Authors:  A S Janssens; R Heide; J C den Hollander; P G M Mulder; B Tank; A P Oranje
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

Review 4.  Signal transduction-associated and cell activation-linked antigens expressed in human mast cells.

Authors:  Peter Valent; Minoo Ghannadan; Alexander W Hauswirth; Gerit-Holger Schernthaner; Wolfgang R Sperr; Michel Arock
Journal:  Int J Hematol       Date:  2002-05       Impact factor: 2.490

Review 5.  An overview of chronic urticaria.

Authors:  Vincent S Beltrani
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

6.  CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis.

Authors:  Niklas Mueller; Daniel Wicklein; Gregor Eisenwort; Mohamad Jawhar; Daniela Berger; Gabriele Stefanzl; Georg Greiner; Alexandra Boehm; Christoph Kornauth; Leonhard Muellauer; Susanne Sehner; Gregor Hoermann; Wolfgang R Sperr; Philipp B Staber; Ulrich Jaeger; Johannes Zuber; Michel Arock; Udo Schumacher; Andreas Reiter; Peter Valent
Journal:  Blood       Date:  2018-07-17       Impact factor: 22.113

7.  The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophils.

Authors:  Katharina Blatt; Harald Herrmann; Irina Mirkina; Emir Hadzijusufovic; Barbara Peter; Sabine Strommer; Gregor Hoermann; Matthias Mayerhofer; Konrad Hoetzenecker; Walter Klepetko; Viviane Ghanim; Katharina Marth; Thorsten Füreder; Volker Wacheck; Rudolf Valenta; Peter Valent
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

8.  Tetraspanins in mast cells.

Authors:  Martin Köberle; Susanne Kaesler; Wolfgang Kempf; Florian Wölbing; Tilo Biedermann
Journal:  Front Immunol       Date:  2012-05-07       Impact factor: 7.561

9.  Expression and function of Allergin-1 on human primary mast cells.

Authors:  Kei Nagai; Satoko Tahara-Hanaoka; Yuko Morishima; Takahiro Tokunaga; Yoshimasa Imoto; Emiko Noguchi; Kazumasa Kanemaru; Masamichi Imai; Shiro Shibayama; Nobuyuki Hizawa; Shigeharu Fujieda; Kunihiro Yamagata; Akira Shibuya
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

Review 10.  Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disorders.

Authors:  P Valent
Journal:  Clin Exp Allergy       Date:  2014-07       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.